Stockscreener 앱 받기
26.50
7.46%
1.84
시간 외 거래:
26.50
전일 마감가:
$24.66
열려 있는:
$24.82
하루 거래량:
679.67K
Relative Volume:
1.95
시가총액:
$852.99M
수익:
$4.85M
순이익/손실:
$-114.75M
주가수익비율:
-8.1538
EPS:
-3.25
순현금흐름:
$-100.36M
1주 성능:
+12.43%
1개월 성능:
+24.76%
6개월 성능:
+16.43%
1년 성능:
-5.29%
1일 변동 폭
$24.48
$27.07
1주일 범위
$23.39
$27.07
52주 변동 폭
$13.37
$32.27
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
명칭
Dianthus Therapeutics Inc
전화
929-999-4055
주소
7 TIMES SQUARE, NEW YORK
DNTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNTH
Dianthus Therapeutics Inc
|
26.50 | 793.76M | 4.85M | -114.75M | -100.36M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-02 | 개시 | William Blair | Outperform |
| 2024-12-20 | 개시 | TD Cowen | Buy |
| 2024-10-03 | 개시 | Oppenheimer | Outperform |
| 2024-07-26 | 개시 | Robert W. Baird | Outperform |
| 2024-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-16 | 개시 | H.C. Wainwright | Buy |
| 2024-02-15 | 개시 | Stifel | Buy |
| 2023-12-26 | 개시 | Jefferies | Buy |
| 2023-11-22 | 개시 | Wedbush | Outperform |
| 2023-10-30 | 개시 | Guggenheim | Buy |
| 2023-09-28 | 개시 | Raymond James | Outperform |
| 2022-08-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-01-06 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-08-20 | 재개 | Goldman | Neutral |
| 2021-08-03 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-22 | 재확인 | B. Riley Securities | Buy |
| 2021-06-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-18 | 개시 | B. Riley Securities | Buy |
| 2021-01-07 | 개시 | Mizuho | Buy |
| 2020-06-08 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-03-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-03-15 | 개시 | Raymond James | Outperform |
모두보기
Dianthus Therapeutics Inc 주식(DNTH)의 최신 뉴스
Should I invest in Dianthus Therapeutics Inc. before earningsJuly 2025 Trends & Free Long-Term Investment Growth Plans - خودرو بانک
Nuveen LLC Acquires New Stake in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Braidwell LP Sells 831,234 Shares of Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Guggenheim reiterates Buy rating on Dianthus Therapeutics stock ahead of data - Investing.com Canada
Does Dianthus Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Big Picture & Safe Entry Point Identification - Newser
Analyzing net buyer seller activity in Dianthus Therapeutics Inc.New Guidance & Capital Efficiency Focused Strategies - Newser
Combining machine learning predictions for Dianthus Therapeutics Inc.2025 Institutional Moves & Weekly Breakout Watchlists - Newser
Heatmap analysis for Dianthus Therapeutics Inc. and competitors2025 Price Targets & Smart Allocation Stock Reports - Newser
Ally Bridge Group NY LLC Cuts Stake in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
What momentum shifts mean for Dianthus Therapeutics Inc.Weekly Risk Summary & Precise Buy Zone Tips - Newser
Is it too late to sell Dianthus Therapeutics Inc.July 2025 Macro Moves & Advanced Technical Signal Analysis - Newser
Published on: 2025-09-05 02:02:07 - Newser
Analysts Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Price Target at $54.00 - MarketBeat
How to build a dashboard for Dianthus Therapeutics Inc. stockWeekly Market Summary & Advanced Technical Analysis Signals - Newser
Is this a good reentry point in Dianthus Therapeutics Inc.2025 Price Targets & Free Real-Time Volume Trigger Notifications - Newser
Will Dianthus Therapeutics Inc. stock go up soonEarnings Recap Report & Low Risk Profit Maximizing Plans - Newser
Is Dianthus Therapeutics Inc. trending in predictive chart modelsWeekly Gains Summary & Risk Managed Trade Strategies - Newser
Best data tools to analyze Dianthus Therapeutics Inc. stockProfit Target & AI Forecast for Swing Trade Picks - Newser
Vestal Point Capital LP Boosts Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Dianthus Therapeutics, Inc. $DNTH Stock Position Increased by RA Capital Management L.P. - MarketBeat
Does Dianthus Therapeutics Inc. fit your quant trading modelTrade Volume Report & Daily Market Momentum Tracking - Newser
Published on: 2025-09-04 04:01:28 - Newser
Visual trend scoring systems applied to Dianthus Therapeutics Inc.Wall Street Watch & Low Drawdown Trading Strategies - Newser
Volatility clustering patterns for Dianthus Therapeutics Inc.July 2025 Volume & Real-Time Stock Price Movement Reports - Newser
Applying Elliott Wave Theory to Dianthus Therapeutics Inc.Options Play & Real-Time Market Sentiment Alerts - Newser
Dianthus Therapeutics Inc. stock trendline breakdownWatch List & Daily Market Momentum Tracking - Newser
Using fundamentals and technicals on Dianthus Therapeutics Inc.Market Rally & Advanced Technical Signal Analysis - Newser
What’s the MACD signal for Dianthus Therapeutics Inc.2025 Risk Factors & Verified Momentum Stock Alerts - خودرو بانک
Backtesting results for Dianthus Therapeutics Inc. trading strategiesQuarterly Portfolio Report & Long-Term Growth Portfolio Plans - Newser
Walleye Capital LLC Increases Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Relative strength of Dianthus Therapeutics Inc. in sector analysisPortfolio Risk Report & Growth Focused Stock Pick Reports - Newser
Elliott Wave Theory Predicts Pullback in Dianthus Therapeutics Inc.Weekly Profit Summary & AI Powered Trade Plan Recommendations - Newser
What data driven models say about Dianthus Therapeutics Inc.’s futureTrade Volume Report & Consistent Profit Focused Trading Strategies - Newser
Is Dianthus Therapeutics Inc. stock showing strong momentumWeekly Gains Report & Risk Managed Investment Signals - خودرو بانک
Can a trend reversal in Dianthus Therapeutics Inc. lead to recovery2025 Momentum Check & Real-Time Market Trend Scan - Newser
Can swing trading help recover from Dianthus Therapeutics Inc. lossesJuly 2025 Highlights & Consistent Growth Stock Picks - Newser
Using R and stats models for Dianthus Therapeutics Inc. forecastingQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Technical signs of recovery in Dianthus Therapeutics Inc.Dividend Hike & AI Optimized Trading Strategy Guides - Newser
Applying big data sentiment scoring on Dianthus Therapeutics Inc.Market Activity Recap & Free Weekly Chart Analysis and Trade Guides - Newser
Nuveen LLC Invests $1.17 Million in Dianthus Therapeutics, Inc. $DNTH - Defense World
What analysts say about Dianthus Therapeutics Inc. stock2025 Sector Review & Technical Pattern Based Signals - خودرو بانک
What is Dianthus Therapeutics Inc.’s book value per shareWeekly Stock Summary & Proven Capital Preservation Tips - خودرو بانک
Is Dianthus Therapeutics Inc. in accumulation or distribution phaseMarket Performance Report & Risk Controlled Stock Pick Alerts - خودرو بانک
What’s the fair value of Dianthus Therapeutics Inc. stockJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - خودرو بانک
Dianthus Therapeutics Inc (DNTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):